PGEN
#1860
Precigen, Inc. - Common Stock
6.8 5 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.44%
Variación mensual
+9.95%
Variación en los últimos 6 meses
+87.67%
Cambio anual
+52.56%
Cierres anteriores
6.9 5
Open
6.8 7
Mínimo
6.8 2
Máximo
6.8 7
Volumen
396
Financials
- Market Capitalization 2.45 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1819 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 22.90 USD | -0.78% | -4.78% | +21.81% | +2.00% | 2.59 B USD | ||
| 1854 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.06 USD | -2.15% | -2.91% | +0.56% | -17.84% | 2.47 B USD | ||
| 1861 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.58 USD | -2.44% | -1.03% | +6.44% | +14.46% | 2.45 B USD | ||
| 1866 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 33.76 USD | -1.26% | 0.00% | +6.10% | +13.52% | 2.43 B USD |